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Introduction
•

•

•

•

•

Substance use disorder
(SUD) is considered the
number one occupational
hazard for certified
registered nurse
anesthetists (CRNAs)
(Rupprecht, 2022).
This topic was chosen
because it is so prevalent in
the anesthesia community.
An estimated 10-15% of
anesthesia providers will be
affected by SUD in their
career (Rupprecht, 2022).
SUD in the anesthesia
profession can only be
decreased by integrating
education and policies that
deal with this issue in a
timely, safe, and nonpunitive manner (AANA,
2021).
The American Association
of Nurse Anesthesiology
(AANA) has many resources
that focus on early
detection, anti-drug
diversion campaigns, and
appropriate response to a
detected issue (AANA,
2021).
The AANA is focusing on an
“alternative to discipline.”
This means that disciplining
the CRNA is not at the
forefront. Instead, the
focus is on successful
rehabilitation with the goal
of being able to return to
work (AANA, 2021).

Signs & Symptoms
of SUD
There are many
indications of an underlying
substance use issue that can
be identified by coworkers.
Early detection is key to a
successful treatment program
(Rupprecht, 2022).
Behavioral changes that an
anesthesia provider may
exhibit include severe mood
swings and personality
changes, confusion, memory
loss, and difficulty
concentrating (Rupprecht,
2022).
Physical indications of
substance use disorder
include deterioration of
appearance and personal
hygiene, bloodshot or glazed
eyes, track marks, weight loss,
and issues sleeping
(Rupprecht, 2022).
Work related issues can
include underperformance,
poorly explained errors,
repetitive tardiness, and
unexplained absences
(Rupprecht, 2022).

Underlying Pathophysiology
The components
contributing to SUD in the
anesthesia provider are a
multifactorial and complex
combination of
psychological, genetic, and
environmental factors.
This poster will focus on
the role of microRNAs in
the pathophysiology of
addiction (Gowen et al.,
2020).
MicroRNAs (miRNAs)
are small, noncoding RNAs
that play a role in posttranscriptional gene
regulation (Gowen et al.,
2020). They are capable of
repression/gene silencing
and can affect many
cellular functions such as
development,
differentiation, growth,
and metabolism. Over
1,900 miRNAs have been
identified in the human
genome, and it is
estimated that there are
hundreds more to be
discovered (Gowen et al.,
2020). To summarize,
miRNAs are tools to
regulate gene expression.

In those suffering with
SUD, several altered miRNA
levels have been identified
(Gowen et al., 2020). Each
substance (such as opiates or
alcohol) affect the alteration
of miRNAs in a different
manner, leading to distinct
consequences. It is well
established that altered gene
expression is associated with
the disfunction of neurons
(Gowen et al., 2020). This
disfunction can be associated
with the behavioral
phenotype of SUD that the
advanced practiced nurse is
familiar with (Gowen et al.,
2020).
MiRNAs were recently
discovered in 1993 (Gowen et
al., 2020). This topic is still
being studied for its
usefulness in identifying and
treating SUD, along with
other disease processes
(Gowen et al., 2020).

Significance of
Pathophysiology
One common misconception
surrounding substance use
disorder is that it is caused by lack
of self control (Rupprecht, 2022).
It is not as well understood that
SUD can physically alter brain
function, leading to additional
issues for those affected
(Rupprecht, 2022).
While the concept of miRNA is
foreign to most advanced practice
nurses and will likely never come
up in daily practice, this topic is
being explored in this way to
demonstrate that SUD can
physically affect brain function
(Gowen et al., 2020).
This presentation intends to
lead the advanced practiced
nurse to treat themselves, their
coworkers, their patients, and
community from a place of
empathy in regards to SUD.

Implications for
CRNAs
The implications of SUD
within the anesthesia
community can not be
understated.
First, the CRNA must be
aware of their own risk for
SUD. Risk factors related to the
anesthesia community include
access to scheduled
medications, working in a high
stress environment,
production pressure,
fatigue/burnout, and poor
work/life balance (AANA,
2021). In addition, each
provider needs to assess their
own risk factors such as family
history, a diagnosis of a mental
health disorder, or a history of
trauma (Rupprecht, 2022).
Secondly, the CRNA must
be aware of the signs and
symptoms of SUD so that they
can identify it if it affects a
coworker. Early identification
and treatment are key in
combatting this disease
(Rupprecht, 2022). Early
detection increases the
chances of a successful
rehabilitation and subsequent
return to work (Rupprecht,
2022).

Conclusions
•

Substance Use Disorder
affects a large percentage
of the anesthesia
community.

•

CNRAs should be aware of
the risk factors associated
with SUD and the
resources available to
help them.

•

CRNAs should be aware of
the signs and symptoms
that someone affected
with SUD may exhibit.
This is because early
identification is better for
treatment.

•

The AANA offers many
recommendations and
resources aimed at
preventing, recognizing,
and treating SUD.

•

miRNAs are tools to
regulate gene expression.
They are just one example
of the way that SUD can
physically alter the human
body.

•

If a CRNA that you know is
suffering with Substance
Use Disorder, you can
contact the AANA’s
helpline at 1-800-6545167

References
American Association of Nurse
Anesthesiology. (2021).
Addressing substance
use disorder in
anesthesia professionals:
Position statement and
policy considerations.
https://www.aana.com/
docs/defaultsource/practice-aanacom-web-documents(all)/professionalpracticemanual/addressingsubstance-use-disorderfor-anesthesiaprofessionals.pdf?sfvrsn=
ff0049b1_10
Gowen, A. M., Odegaard, K. E.,
Hernandez, J., Chand, S.,
Koul, S., Pendyala, G., &
Yelamanchili, S. V.
(2020). Role of micrornas
in the pathophysiology of
addiction. WIREs RNA,
12(3).
https://doi.org/10.1002/
wrna.1637
Rupprecht, N. (2022). The impaired
anesthesia provider:
Strategies to prevent,
recognize, and treat
substance use disorder
within the workplace.
AANA Journal, 90(1), 64–
70.
https://eds.s.ebscohost.c
om/eds/detail/detail?vid
=18&sid=e019895b0557-4661-b76c1e7e22045bae%40redis
&bdata=JnNpdGU9ZWRz
LWxpdmUmc2NvcGU9c2l
0ZQ%3d%3d#AN=155210
473&db=c9h

(~
OTTERBEIN
UNIVERSITY

Figure 1: Relative likelihood of opiate and alcohol abuse over the course of an
anesthetic career (AANA, 2021).

Figure 2: The underlying genes in the drug addiction pathway in relation to miRNAs
(Gowen et al., 2020).
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